Overview

Physical Exercise Versus Rosiglitazone in CAD and Prediabetes

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to prospectively assess the relative benefits of either treatment with rosiglitazone or physical exercise on endothelial function in patients with impaired fasting glucose or impaired glucose tolerance and coronary artery disease (CAD).
Phase:
Phase 4
Details
Lead Sponsor:
University of Leipzig
Treatments:
Rosiglitazone